OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Mobility Consulting Group, LLC

1 Projects | 0 Researchers | $1,148,580 Invested

2021

Mobility Consulting Group, LLC

Diagnostics Accelerator Speech & Language Consortium: Harmonized Repository for the Exploration of Speech and Language Biomarkers for Neurodegenerative Disease

  • Funding Amount: $1,148,580
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Status: Active